Publications by authors named "Ute Moll"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

23,544

Total Likes

608

Extended Reach

110,422

Social Features

22
E
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.
Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, Tiago De Oliveira, Lena-Christin Conradi, Ute M Moll

Cell Death Differ· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.
Nicole Concin, Ioana Braicu, Pierre Combe, Regina Berger, Isabelle Ray-Coquard, Ute M Moll

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Expression of Concern: p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity.
Sonja Wolff, Susan Erster, Gustavo Palacios, Ute M Moll

Cell Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo.
Flaminia Talos, Oleksi Petrenko, Patricio Mena, Ute M Moll

Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Eva Obermayr, Thomas Mohr, Eva Schuster, Elena Ioana Braicu, Eliane Taube, Ute Martha Moll

Int J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: TAp73 is a central transcriptional regulator of airway multiciliogenesis.
Alice Nemajerova, Daniela Kramer, Saul S Siller, Christian Herr, Orr Shomroni, Ute M Moll

Genes Dev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.
Christopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, Natalia Estrada, Friederike Christen, Ute Martha Moll

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.
Christopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, Natalia Estrada, Friederike Christen, Ute Martha Moll

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.
Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, Tiago De Oliveira, Lena-Christin Conradi, Ute M Moll

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Bing Z Carter, Po Yee Mak, Muharrem Muftuoglu, Wenjing Tao, Baozhen Ke, Ute M Moll

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53.
Maria-Riera Piqué-Borràs, Zivojin Jevtic, Frederik Otzen Bagger, Jonathan Seguin, Rathick Sivalingam, Ute M Moll

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A Aaronson, John M Abrams, Ute M Moll

Cell Death Differ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells.
Luisa Klemke, Clara F Fehlau, Nadine Winkler, Felicia Toboll, Shiv K Singh, Ute M Moll

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity.
Tamara Isermann, Özge Çiçek Şener, Adrian Stender, Luisa Klemke, Nadine Winkler, Ute M Moll

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Alexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, Cathy Ignacimouttou, Alexis Caulier, Ute Moll

Blood· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin as anti-cancer therapy in autochthonous T-lymphomas expressing stabilized gain-of-function mutant p53 proteins.
Karis Tutuska, Laura Parrilla-Monge, Erica Di Cesare, Alice Nemajerova, Ute M Moll

Cell Death Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific roles of p73 in development and homeostasis.
Alice Nemajerova, Ute M Moll

J Cell Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cajal-Retzius neurons are required for the development of the human hippocampal fissure.
Gundela Meyer, Emilio González-Arnay, Ute Moll, Alice Nemajerova, Fadel Tissir

J Anat· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.
Isabelle Ray-Coquard, Ioana Braicu, Regina Berger, Sven Mahner, Jalid Sehouli, Ute Martha Moll

Front Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells.
Daniela Kramer, Nadine Stark, Ramona Schulz-Heddergott, Norman Erytch, Shelley Edmunds, Ute M Moll

Cell Death Differ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion.
Ramona Schulz-Heddergott, Nadine Stark, Shelley J Edmunds, Jinyu Li, Lena-Christin Conradi, Ute M Moll

Cancer Cell· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.
Ramona Schulz-Heddergott, Ute M Moll

Cancers (Basel)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.
Alice Nemajerova, Ivano Amelio, Jakob Gebel, Volker Dötsch, Gerry Melino, Ute M Moll

Cell Death Differ· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner.
Evguenia M Alexandrova, Sulan Xu, Ute M Moll

Cell Death Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis